- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05028452
Feasibility of Internet Based Support (Carer eSupport) for Informal Caregivers of Patients With Head and Neck Cancer
February 15, 2024 updated by: Uppsala University
Carer eSupport: Rationale and Design of an Internet-based Support for Informal Caregivers of Individuals With Head and Neck Cancer
Informal caregivers to patients with head and neck cancer report that they are unprepared for caregiving, that they experience a high caregiver burden and a deteriorated health.
The aim is to develop an internet based intervention for informal caregivers of individuals with head and neck cancer and evaluate the feasibility and acceptability of the intervention.
The internet based intervention (Carer eSupport) will be based on scientific evidence, established theoretical frameworks and focus groups with caregivers and health care professionals.
The feasibility and acceptability of Carer eSupport will be evaluated by 30 caregivers who will have access to Carer eSupport during one months.
The feasibility and acceptability of Carer eSupport will be evaluated with quantitative and qualitative data.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Birgitta Johansson, Docent
- Phone Number: +46704250912
- Email: birgitta.johansson@igp.uu.se
Study Contact Backup
- Name: Ulrica Langegård, PhD
- Phone Number: +46729999020
- Email: ulrica.langegard@igp.uu.se
Study Locations
-
-
Blekinge Län
-
Örebro, Blekinge Län, Sweden, 70185
- Orebro University Hospital
-
-
Uppsala Län
-
Uppsala, Uppsala Län, Sweden, 75105
- Uppsala University Hospital
-
-
Västerbottens Län
-
Umeå, Västerbottens Län, Sweden, 90737
- Norrland University Hospital
-
-
Västra Götaland
-
Göteborg, Västra Götaland, Sweden, 41345
- Sahlgrenska University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Informal caregivers (defined by the patients) to patients with head and neck cancer who are about to start treatment, undergoing treatment or have completed treatment within the past month.
Exclusion Criteria:
- Confusion or dementia, inability to understand, speak or read Swedish.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Internet based support
Internet based support for informal caregivers to individuals who are undergoing treatment for head and neck cancer.
|
Carer eSupport is designed to prepare informal caregivers for caregiving, to decrease caregiver burden and prevent a deteriorated health.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inclusion rate
Time Frame: 4 months
|
The proportion of caregivers who give informed consent for participation
|
4 months
|
Utilization of Carer eSupport
Time Frame: 2 months
|
The proportion of included caregivers who take use of Carer eSupport
|
2 months
|
Attrition
Time Frame: 3 months
|
The proportion of included caregivers who withdraw from the study
|
3 months
|
Completion of questionnaires
Time Frame: 3 months
|
The proportion of included caregivers who complete questionnaires
|
3 months
|
Perceived feasibility
Time Frame: Within 1 months after completion of testing Carer eSupport.
|
Qualitative data from semi-structured individual interviews exploring perceived feasibility of Carer eSupport.
|
Within 1 months after completion of testing Carer eSupport.
|
Perceived acceptability
Time Frame: Within 1 months after completion of testing Carer eSupport.
|
Qualitative data from semi-structured individual interviews exploring perceived acceptability of Carer eSupport.
|
Within 1 months after completion of testing Carer eSupport.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Preparedness for caregiving scale
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport
|
A brief 8-item self-report measure assessing preparedness for caregiving, a potential primary outcome in a future randomized controlled trial.
|
Assessed at baseline and at 1 months after access to Carer eSupport
|
Caregiver´s burden scale
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
|
A 22-item self-report measure assessing caregiver burden, a potential primary outcome in a future randomized controlled trial.
|
Assessed at baseline and at 1 months after access to Carer eSupport.
|
Short Form Health Survey (SF-36), v2.
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
|
A 36-item self-report measure assessing self-perceived health, a potential secondary outcome in a future randomized controlled trial.
|
Assessed at baseline and at 1 months after access to Carer eSupport.
|
The Depression Anxiety Stress Scale-21
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
|
A 21-item self-report measure assessing depression, anxiety, and stress, a potential secondary outcome in a future randomized controlled trial.
|
Assessed at baseline and at 1 months after access to Carer eSupport.
|
The Multidimensional fatigue inventory
Time Frame: Assessed at baseline and at 1 months after access to Carer eSupport.
|
A 20-item self-report measure assessing five dimensions of fatigue, a potential secondary outcome in a future randomized controlled trial.
|
Assessed at baseline and at 1 months after access to Carer eSupport.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Birgitta Johansson, Docent, Uppsala University, Department of Immunology, Genetics and pathology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2023
Primary Completion (Actual)
September 30, 2023
Study Completion (Actual)
September 30, 2023
Study Registration Dates
First Submitted
August 24, 2021
First Submitted That Met QC Criteria
August 24, 2021
First Posted (Actual)
August 31, 2021
Study Record Updates
Last Update Posted (Actual)
February 16, 2024
Last Update Submitted That Met QC Criteria
February 15, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Carer eSupport
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to make individual participant data (IPD) available to other researchers, since this is a feasibility study.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicRecruitingCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedHead And Neck CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Radboud University Medical CenterUnknown
-
Centre Oscar LambretUnknownEpidermoid Head and Neck CancerFrance
Clinical Trials on Internet based support
-
Dartmouth-Hitchcock Medical CenterRecruiting
-
Göteborg UniversitySödra Älvsborg Hospital; Habilitation Services in Skaraborg, SkövdeCompletedADHD | Autism Spectrum DisordersSweden
-
Karolinska InstitutetCompletedObsessive Compulsive DisorderSweden
-
Medical University of ViennaPharmig - Gesundheitsziele aus dem Rahmen-PharmavertragCompleted
-
Vardalinstitutet The Swedish Institute for Health...CompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Tourette's Disorder
-
Karolinska InstitutetRegion StockholmRecruiting
-
Karolinska InstitutetCompletedObsessive-compulsive DisorderSweden
-
Linkoeping UniversityNot yet recruiting
-
The Gerocenter Foundation for Research and DevelopmentCompletedQuality of Life | Depressive Symptoms | Psychological DistressFinland
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Not yet recruitingStage IV Lung Cancer | Stage III Lung Cancer | Stage II Lung Cancer